In 2004, NIAID and NIDDK began inviting investigators to apply for funds for research in transplantationtolerance in non-human primate models of islet and/or kidney transplantation. Funds for this novel researchwere awarded to the Non-Human Primate Transplant Tolerance Cooperative Study Group (NHPCSG).Emory University was asked to administer these funds through the awarding of Opportunities Poolsubcontracts under our existing parent grant. To date, fourteen proposals have been processed throughreview, resulting in the administration of five awarded subcontracts. We are currently actively solicitingproposals for a third round of funding and propose to lead the administration of efforts in subsequent rounds.In addition, in September, 2005, the Emory Transplant Center (ETC) hosted a Non-Human Primate (NHP)Assays Workshop at Emory University. This workshop brought together lab personnel from more than adozen labs across the NHPCSG to share assay protocols and techniques. As part of this Workshop, wecreated a website where NHPCSG investigators and their laboratories could access the workshop agenda,slides from presenters, protocols shared by laboratories, and information on the NIH-sponsored primatecolony. This website was highly successful and is evidence that the NHPCSG members and theirlaboratories would benefit from a tool to facilitate communication and information exchange. Thecornerstone of these electronic communications will be the proposed NHPCSG website, which will build onthe existing resources created for the ETC website and the adjunct NHP Assays Workshop pages. Webelieve that these two programs can be synergistic. As part of the NHPCSG website, we propose to bringadded value to the interactions and collaborative efforts of the consortium members initially through the useof the limited-access, web-based, collaborative software tool Blackboard. Immediately, Blackboard can beused by Consortium members to asynchronously post and review shared information, documents, data, andtools. In addition, we propose to use this program to improve the administration of the current and futureOpportunities Pool funding by creating a more secure and efficient venue for review of future OpportunitiesPool submissions. Later, the same capabilities can be utilized and expanded through a customized portal forthe NHPCSG. Through the use of Blackboard, and eventually a portal, we can further improve theprocesses of the Opportunities Pool as well as help to synergize the research of the investigators across theConsortium. Over the course of the past two and a half years, we have acquired the experience necessaryto streamline the processes associated with the administration of the Opportunities Pool. We propose tobuild on the skills we have developed thus far in the future implementation of both the Opportunities PoolDiscretionary Fund and the expanded NHPCSG website.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI051731-07
Application #
7632236
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2008-06-01
Project End
2009-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
7
Fiscal Year
2008
Total Cost
$734,242
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Mathews, David V; Dong, Ying; Higginbotham, Laura B et al. (2018) CD122 signaling in CD8+ memory T cells drives costimulation-independent rejection. J Clin Invest 128:4557-4572
Kean, Leslie S (2018) Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis. Blood 131:2630-2639
Colonna, Lucrezia; Peterson, Christopher W; Schell, John B et al. (2018) Evidence for persistence of the SHIV reservoir early after MHC haploidentical hematopoietic stem cell transplantation. Nat Commun 9:4438
Song, M; Mulvihill, M S; Williams, K D et al. (2018) Fatal SV40-associated pneumonia and nephropathy following renal allotransplantation in rhesus macaque. J Med Primatol 47:81-84
Taraseviciute, Agne; Tkachev, Victor; Ponce, Rafael et al. (2018) Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman Primates. Cancer Discov 8:750-763
Ezekian, Brian; Schroder, Paul M; Freischlag, Kyle et al. (2018) Contemporary Strategies and Barriers to Transplantation Tolerance. Transplantation 102:1213-1222
Manook, M; Kwun, J; Burghuber, C et al. (2017) Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation. Am J Transplant 17:2055-2064
Samy, K P; Anderson, D J; Lo, D J et al. (2017) Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model. Am J Transplant 17:1193-1203
Kwun, Jean; Burghuber, Christopher; Manook, Miriam et al. (2017) Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates. Blood Adv 1:2115-2119
Tkachev, Victor; Furlan, Scott N; Watkins, Benjamin et al. (2017) Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant. Sci Transl Med 9:

Showing the most recent 10 out of 73 publications